Categories: Government agency news release

8/20/2018

NIH brings balance to recap of study on blood test for gestational diabetes

1 2/22/2018

Potential harms and source of evidence missing in FDA summary of new blood test for concussion

2/15/2018

NIH recap on ‘brain disease test’: strong on study results, but lacks clarity on patient benefits

5/5/2017

Key detail missing in FDA approval of new acute myeloid leukemia drug: How much longer do people live?

4/4/2017

FDA could do a better job sharing numbers on costly new eczema drug

3/14/2017

FDA omits numbers on drug to reduce night-time visits to the bathroom; placebo was nearly as good

2/20/2017

FDA announces approval of new psoriasis drug with strong caveats on harms, but no data to support benefit claim

2/7/2017

NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations

2 1/31/2017

How big is symptom improvement with new constipation drug? Readers might have to strain to find out

1/4/2017

Fenofibrate as add-on to statins for type 2 diabetes: NIH release promotes possible benefit found only in small subgroup of patients

News Release Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

Laura Marston @Kidfears99·

A great read on this weekend’s NYT claims of a cure for Type 1.

Cure for Type 1 diabetes? We’ve been down this road before with NY Times https://www.healthnewsreview.org/2021/11/cure-for-type-1-diabetes-weve-been-down-this-road-before-with-ny-times/

Reply on Twitter 1465416998746308611 Retweet on Twitter 146541699874630861118 Like on Twitter 146541699874630861151 Twitter 1465416998746308611

Retweet on Twitter HealthNewsReview.org Retweeted

Chris Hendel @chrishendel·

"But it is the framing and the emphasis of the #journalism by a leading science journalist at a leading newspaper that demands scrutiny. It has an impact on readers and on sick people that may cause harm by promoting false hope about extremely preliminary research"

👍👏💪 truth https://twitter.com/garyschwitzer/status/1465399358137024518

Reply on Twitter 1465403458618634241 Retweet on Twitter 14654034586186342412 Like on Twitter 14654034586186342417 Twitter 1465403458618634241

Retweet on Twitter HealthNewsReview.org Retweeted

Adam Cifu @adamcifu·

Why we should still miss healthnewsreview. https://twitter.com/garyschwitzer/status/1465399358137024518

Reply on Twitter 1465403534606749701 Retweet on Twitter 14654035346067497013 Like on Twitter 146540353460674970115 Twitter 1465403534606749701

Categories: Government agency news release

NIH brings balance to recap of study on blood test for gestational diabetes

Potential harms and source of evidence missing in FDA summary of new blood test for concussion

NIH recap on ‘brain disease test’: strong on study results, but lacks clarity on patient benefits

Key detail missing in FDA approval of new acute myeloid leukemia drug: How much longer do people live?

FDA could do a better job sharing numbers on costly new eczema drug

FDA omits numbers on drug to reduce night-time visits to the bathroom; placebo was nearly as good

FDA announces approval of new psoriasis drug with strong caveats on harms, but no data to support benefit claim

NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations

How big is symptom improvement with new constipation drug? Readers might have to strain to find out

Fenofibrate as add-on to statins for type 2 diabetes: NIH release promotes possible benefit found only in small subgroup of patients

News Release Reviews

@HealthNewsRevu

Categories

Tags